Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Mol Cell Biol ; 27(14): 5147-60, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17515611

ABSTRACT

Tumor necrosis factor alpha (TNF-alpha) is a potent cytokine which regulates inflammation via the induction of adhesion molecules and chemokine expression. Its expression is known to be regulated in a complex manner with transcription, message turnover, message splicing, translation, and protein cleavage from the cell surface all being independently regulated. This study examined both cell lines and primary cells to understand the developmental regulation of epigenetic changes at the TNF-alpha locus. We demonstrate that epigenetic modifications of the TNF-alpha locus occur both developmentally and in response to acute stimulation and, importantly, that they actively regulate expression. DNA demethylates early in development, beginning with the hematopoietic stem cell. The TNF-alpha locus migrates from heterochromatin to euchromatin in a progressive fashion, reaching euchromatin slightly later in differentiation. Finally, histone modifications characteristic of a transcriptionally competent gene occur with myeloid differentiation and progress with differentiation. Additional histone modifications characteristic of active gene expression are acquired with stimulation. In each case, manipulation of these epigenetic variables altered the ability of the cell to express TNF-alpha. These studies demonstrate the importance of epigenetic regulation in the control of TNF-alpha expression. These findings may have relevance for inflammatory disorders in which TNF-alpha is overproduced.


Subject(s)
Epigenesis, Genetic , Tumor Necrosis Factor-alpha/genetics , Acetylation/drug effects , Adenosine/analogs & derivatives , Adenosine/pharmacology , Animals , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Nucleus/drug effects , Cell Nucleus/metabolism , DNA Methylation/drug effects , Embryonic Stem Cells/cytology , Embryonic Stem Cells/drug effects , Epigenesis, Genetic/drug effects , Euchromatin/metabolism , Histones/metabolism , Humans , In Situ Hybridization, Fluorescence , Mice , Models, Genetic , Protein Transport/drug effects , Sulfites , Thionucleosides/pharmacology
2.
Clin Genet ; 67(4): 335-40, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15733270

ABSTRACT

Primary congenital glaucoma (PCG) has been associated with CYP1B1 gene (2p21), with a predominantly autosomal recessive mode of inheritance. Our earlier studies attributed CYP1B1 mutations to only 40% of Indian PCG cases. In this study, we included 72 such PCG cases where CYP1B1 mutations were detected in only 12 patients in heterozygous condition, implying involvement of other gene(s). On screening these patients for mutations in myocilin (MYOC), another glaucoma-associated gene, using denaturing high-performance liquid chromatography followed by sequencing, we identified a patient who was double heterozygous at CYP1B1 (c.1103G>A; Arg368His) and MYOC (c.144G>T; Gln48His) loci, suggesting a digenic mode of inheritance of PCG. In addition, we identified the same MYOC mutation, implicated for primary open angle glaucoma, in three additional PCG patients who did not harbor any mutation in CYP1B1. These observations suggest a possible role of MYOC in PCG, which might be mediated via digenic interaction with CYP1B1 and/or an yet unidentified locus associated with the disease.


Subject(s)
Eye Proteins/genetics , Glaucoma/congenital , Glaucoma/genetics , Glycoproteins/genetics , Aryl Hydrocarbon Hydroxylases/genetics , Cytochrome P-450 CYP1B1 , Cytoskeletal Proteins , Female , Haplotypes , Humans , Male , Point Mutation
SELECTION OF CITATIONS
SEARCH DETAIL